The iSMART Diagnostic Booths represent a groundbreaking advancement in healthcare, leveraging state-of-the-art Artificial Intelligence (AI), Machine Learning (ML), and Deep Learning technologies to provide accurate and timely disease diagnosis and management.
The early success of iSMARTⓇ highlighted AI’s potential to revolutionise diagnostics beyond COVID-19. The third-generation system expanded its scope to include the detection of other respiratory infections, metabolic disorders, and even certain cancers. By leveraging AI’s ability to analyse diverse biomarkers, iSMARTⓇ will become a versatile diagnostic tool capable of transforming healthcare pathways.
During this phase, we are planning to create private consultation diagnostic booths, enabling deployment in a variety of settings, including hospitals, GP surgeries, and public spaces.
The fully automated, standalone system will be designed to deliver rapid, non-invasive, and highly accurate diagnostics.
The system captures data on 38,238 known diseases and integrates 40 pharmacopeias, providing detailed information on human diseases and their genetic relationships.
The booth is designed to be intuitive and accessible, with machine learning capabilities which requires minimal training for operators or users.
Data from the booth can be transmitted securely to healthcare providers and public health systems, enabling coordinated responses to manage patients and any emerging health threats.
Cutting-edge algorithms provide instant results, significantly reducing the time required for diagnosis.
Building on the original technology, these sensors are now optimised to detect a wide range of diseases from breath samples.
This integration allows medical professionals to see more patients in less time, optimising healthcare resources.
